| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 15 |
| 1 | METHOTREXATE | 11 |
| 2 | HYDROXOCOBALAMIN | 10 |
| 3 | SERTRALINE | 10 |
| 4 | ADALIMUMAB | 7 |
| 5 | ADALIMUMAB-AATY | 7 |
| 6 | ADALIMUMAB-ADAZ | 7 |
| 7 | ADALIMUMAB-FKJP | 7 |
| 8 | ASPIRIN | 7 |
| 9 | ASPIRIN 325 MG | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PORACTANT ALFA | 4 | 0.0054 |
| 1 | SIBEPRENLIMAB | 2 | 0.0029 |
| 2 | HYDROXOCOBALAMIN | 10 | 0.0024 |
| 3 | TRIHEPTANOIN | 1 | 0.0018 |
| 4 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 5 | PROPAFENONE | 7 | 0.0016 |
| 6 | ALCAFTADINE | 1 | 0.0011 |
| 7 | DACTINOMYCIN | 2 | 0.0009 |
| 8 | DOPAMINE HYDROCHLORIDE | 3 | 0.0008 |
| 9 | VASOPRESSIN | 3 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 11 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 11 |
| 2 | Antidote [EPC] | 10 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 4 | Catecholamine [EPC] | 8 |
| 5 | Interleukin-17A Antagonist [EPC] | 8 |
| 6 | Atypical Antipsychotic [EPC] | 7 |
| 7 | Insulin [EPC] | 7 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 7 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 4 | 0.0034 |
| 1 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 2 | Actinomycin [EPC] | 2 | 0.0009 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 4 | Interleukin-17A Antagonist [EPC] | 8 | 0.0002 |
| 5 | Antidote [EPC] | 10 | 0.0002 |
| 6 | Insulin [EPC] | 7 | 0.0002 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 3 | 0.0001 |
| 9 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |